Johnson & Johnson’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Johnson & Johnson’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000,000	Closed	-$6.67M	–	26
2023 Q3	$6.67M	Hold	1,000,000	–	–	2.46%	11
2023 Q2	$9.06M	Hold	1,000,000	–	–	2.81%	9
2023 Q1	$7.27M	Hold	1,000,000	–	–	2.36%	10
2022 Q4	$7.29M	Hold	1,000,000	–	–	2.12%	11
2022 Q3	$7.73M	Hold	1,000,000	–	–	2.27%	12
2022 Q2	$6.81M	Hold	1,000,000	–	–	1.74%	12
2022 Q1	$7.97M	Hold	1,000,000	–	–	1.51%	12
2021 Q4	$5.6M	Hold	1,000,000	–	–	0.64%	13
2021 Q3	$7.69M	Buy	+1,000,000	New	+$9.12M	0.67%	12

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Johnson & Johnson's PNT Position: Q4 2023 in Review

Johnson & Johnson sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 1,000,000 shares — an estimated $6.67M sold.

Johnson & Johnson first reported a position in PNT in Q3 2021 and held it in 9 quarters. The position peaked at $9.06M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Johnson & Johnson reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Johnson & Johnson sold 1,000,000 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $6.67M.
Johnson & Johnson first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Johnson & Johnson's POINT Biopharma Global Inc. Common Stock position peaked at $9.06M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Johnson & Johnson's 13F filing for Q4 2023, filed 14 Feb 2024.